Exactis Innovation is a leading brand in precision oncology research. Since its founding in 2014, Exactis has become a renowned Business-Led Networks Centres of Excellence (BL-NCE) that brings together public and private partners in the field of cancer research. With a network of 16 oncology centers across Canada, Exactis focuses on developing innovative solutions for personalized cancer treatment.

One of the key services offered by Exactis is their Personalize My Treatment (PMT) program, which acts as a comprehensive cancer patient registry. This program collects and analyzes both clinical and molecular data, enabling healthcare professionals to tailor treatments based on individual patient profiles. In addition, Exactis has a dedicated team of experts in clinical and translational operations, specializing in biomarker-based clinical trials and translational research.

Their extensive network and PMT registry allow for real-world effectiveness assessments in precision oncology. Exactis is committed to upholding the highest ethical and professional standards, ensuring the rights and privacy of patients. Their values of integrity, patient-focus, innovation, collaboration, inclusiveness, and performance-driven approach guide their mission to accelerate precision oncology through the integration of molecular and clinical profiles.

Testimonials from investigators and sponsors highlight the invaluable support provided by Exactis, emphasizing their efficiency and dedication in regulatory matters, monitoring, and data management. With Exactis, healthcare stakeholders have the power to improve cancer survivorship through timely data-driven insights, ultimately revolutionizing the field of oncology research